Antiatherogenic actionof nitrendipine in hypercholesterolemic rabbits: Changes in aortic macrophage accumulation and smooth muscle cell phenotype

Journal of Vascular Research

Volumn 33, Issue 1, 1996, Pages 5-12

  Pauletto, Paolo ^a   Da Ros, Santina ^a   Faggin, Elisabetta ^a   Zanetti, Giuseppe ^a   Pessina, Achille C ^a   Faggiotto, Agostino ^b   Sartore, Saverio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Bayer SpA Italy   (Italy)

Author keywords

Arterial wall; Atherosclerosis; Atherosclerosis prevention; Calcium antagonists; Macrophages; Smooth muscle cells

Indexed keywords

CALCIUM ANTAGONIST; MYOSIN HEAVY CHAIN; NITRENDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; HYPERCHOLESTEROLEMIA; MACROPHAGE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHENOTYPE; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0030030219     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159126     Document Type: Article

References (29)

1. Pauletto P, Sarlore S, Giurialo L, Scalena M, Tonello M, Scannapicco G, Pessina AC, Dal Palu C: Calcium antagonists and vascular smooth muscle cells in atherogencsis, J Car-diovasc Pharmacol 1992:19:S8-S16.
2. Henry PD: Calcium antagonists as anti-athcro-sclerotic agents, Arteriosclerosis 1990:10:963-965.
3. Nilsson J, Sjolund M, Palmberg L, Von Euler AM, Jonzon B, Thyberg J: The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation, Atherosclerosis 1985:58: 109-122.
4. Pauletto P, Scannapicco G, Borrione AC, Za-nellato AMC, Tonello M, Giuriato L, Pessina AC, Dal Palu C, Sartore S: A nifedipine-sensitive smooth muscle cell population is present in the atherosclerotic rabbit aorta, Arterioscler Thrornb 1991:11:928-939.
5. Nomoto A, Hirosumi I, Sekiguchi C, Mutoh S, Yamaguchi I, Aoki H: Antiatherogenic activity of FR 34235 (nilvadipinc), a new potent calcium antagonist, Atherosclerosis 1987.64:255-261.
6. Stein O, Leitersdorf E, Stein Y: Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture, Arteriosclerosis 1985:5:35-44.
7. Schmitz G, Robenek H, Beuck M, Krause R, Schurck A, Niemann R: Ca" antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms, I: Characterization of cellular lipid metabolism, Arteriosclerosis 1988:8:46-56.
8. Orekhov AN, Tertov VV, Khashimov KA, Kudryashov SS, Smirnov VN: Evidence of anti-atherosclerotic action of verapamil from direct effects on arterial cells, Am J Cardiol 1987:59: 495-496.
9. Strohschneider T, Betz E: Densitomelric measurement of increased endothelial permeability in atherosclerotic plaques and inhibition of permeability under the influence of two calcium antagonists, Atherosclerosis 1989:75: 135-144.
10. Stender S, Ravn H, Haugegaard M, Kjeldsen K: Effect of verapamil on accumulation of free and esterified cholesterol in the thoracic aorta of cholcstcrol-fcd rabbits, Atherosclerosis 1986;61:15-23.
11. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s, Nature 1993:362: 801-809.
12. Thyberg J, Iledin U, Sjolund M, Palmberg L, Botlger BA: Regulation of differentiated prop-ertiesand proliferation of arterial smooth muscle cells, Arteriosclerosis 1990:10:966-990.
13. Zanellato AMC, Borrione AC, Tonello M, Scannapieco G, Pauletto P, Sartore S: Myosin isoform expression and cell heterogeneity in normal and atherosclerotic rabbit aorta, Arteriosclerosis 1990:10:996-1009.
14. Pauletto P, Chiavcgato A, Giurato L, Scatena M, Faggin E, Griscnti A, Sarzani L, Paci MV, Dessi Fulgeri P, Rappclli A, Pessina AC, Sartore S: Hyperplastic growth of aortic smooth muscle cells in renovascular hypertensive rabbits is characterized by the expansion of an immature cell phenotype, Circ Res 1994:74: 744-788.
15. Frid MG, Printseva OY, Chiavcgato A, Faggin E, Koteliansky VE, Pauletto P, Glukhova MA, Sartore S: Myosin heavy-chain composition in developing and adult human aortic smooth muscle, J Vase Res 1993;30:279-292.
16. Giuriato L, Scatena M, Chiavcgato A, Tonello M, Scannapicco G, Pauletto P, Sartore S: Nonmuscle myosin isoforms and cell heterogeneity in developing rabbit vascular smooth muscle, J Cell Sci 1992:101:233-246.
17. Borrione AC, Zanellato AMC, Scannapicco G, Pauletto P, Sartore S: Myosin heavy chain isoforms in adult and developing rabbit vascular smooth muscle, Eur J Biochem 1989:183:413-417.
18. Pauletto P, Sartore S, Giuriato L, Scatena M, Giudolin D, Scannapicco G, Pessina AC: Com-puterdriven assessment of 'immature' type smooth muscle cells in rabbit aorta, J Hyper-tens 1991;9(suppl 6): 180.
19. Giuriato L, Scatena M, Chiavcgato A, Zanellato AMC, Guidolin D, Pauletto P, Sartore S: Localization and smooth muscle cell composition of atherosclerotic lesions in Watanabc heritable hypcrlipidemic rabbits, Arterioscler Thromb i993:13:347-359.
20. Lichtlen PR, Hugcnholtz PG, RafTcnbcul W, Hecker H, Jost S, Deckers JW: Retardation of angiographic progression of coronary artery disease by nifedipine: Results of International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT), Lancet 1990:335:1109-1113.
21. Waters D, Lespcrance J, Francetich M, Causey D, Theroux P, Chang YK, Hudon G, Lemarbre L, Reitman M, Joyal M, Gosselin G, Dyrda I, Macer Y, Havel RJ: A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis, Circulation 1990:82:1940-1953.
22. Schmitz G, Assmann G: A quantitative densi-tomctric method for the rapid separation and quantitation of the major tissue and lipoprotein lipids by high performance thin layer chromatography, 1: Sample preparation, Chromatography and densitometry, J Chromatogr 1984:307:65-79.
23. Sartore S, Scatcna M, Chiavcgato A, Faggin E, Giuriato L, Pauletto P: Myosin isoform expression in smooth muscle cells during physiological and pathological remodeling, J Vase Res 1994:31:61-81.
24. Carnemolla B, Borsi L, Zardi L, Owens RJ, Barelle FE: Localization of the cellular-fibro-nectin-spccific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E, coli, FEBS Lett 1987:215: 269-273.
25. Tsukada T, Roscnfcld M, Ross R, Gown AM: Immunocytochemical analysis of cellular components in atherosclerotic lesions: Use of monoclonal antibodies with the Watanabc and fat-fed rabbit, Arteriosclerosis 1986:6:601-613.
26. Glukhova MA, Frid M, Shekhonin B, Balabanov Y, Koteliansky VE: Expression of extra domain A fibronectin sequence in vascular smoolh muscle cells is phenotype dependent, J Cell Biol 1989;109:357-366.
27. Aikawa M, Sivam PN, Kuro-o M, Kimura K, Nakahara K, Takewaky S, Ueda M, Yamaguchi H, Yazaki L, Periasamy M: Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis, Circ Res 1993:73:1000-1012.
28. Simons M, Leclerc G, Saftan RD, Isner JM, Weir L, Bairn DS: Relation between activated smooth muscle cells in coronary' artery lesions and restenosis after atherectomy, N Engl J Med 1993;328:608-613.
29. Simons M, Rosenberg RD: Antisense non-muscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro, Circ Res 1992:70:835-840.